In Successful Cancer Trial, Therapy "Dissolves" Stage IV Tumor in 3 Weeks

 
Related

Stop Everything and Watch This Disney Princess Medley

Good News
682 points

Man Gives Old Shelter Dogs Free Haircuts So They Can Finally Find Homes

Good News
358 points



Most recent

El cambio climático pone en peligro las reservas mundiales de Omega-3

NOTICIAS-ETF
12 points

Simplemente Gracias, la nueva apuesta de LOS TRI-O por la música romántica

TECH2022
32 points

La ola d calor no frena las infecciones respiratorias: no lo habíamos visto nunca, dicen los médicos

NOTICIAS-ETF
14 points

Hallan en la Antártida superbacterias capaces de generar nuevas enfermedades

NOTICIAS-ETF
24 points

La mosca levantó el vuelo... y desperté

El diario de Enrique
14 points

Volvo ya prueba camiones con hidrógeno: 1.000 km de autonomía, solo 15 minutos de repostaje

NOTICIAS-ETF
12 points

11 años como referente de hospitalidad: Holiday Inn Cartagena Morros

Comunicaciones
12 points

LO VAMOS A EXTRAÑAR SENADOR ROBLEDO.

pensamiento Libre
98 points

Muere d un golpe de calor un bebé al que sus padres olvidaron en el asiento d atrás del coche (EEUU)

NOTICIAS-ETF
10 points

Teníamos diecisiete años

El diario de Enrique
8 points
SHARE
TWEET
An experimental drug combination dissolved a cancerous tumor so fast, it caught researchers completely off-guard. The two-drug combo completely eliminated a woman’s melanoma — and left her completely cancer-free — in just three weeks.

In Successful Cancer Trial, Therapy "Dissolves" Stage IV Tumor in 3 Weeks

Researchers were surprised at how well the drug combination worked, shrinking tumors at least 80% in more than half of the 142 patients in the trial. And the combination completely eradicated tumors in 22% of patients.

In the rapid recovery case, a 49-year-old woman was given the drugs to treat a large tumor on her chest. Doctors continued to monitor her after the treatment and she remains cancer-free. (The image on the left shows the cancer mass with an asterisk* and the photo on the right is magnified)

“I was astonished; I’d never seen anything like that,” Dr. Paul Chapman, head of the melanoma section at the Memorial Sloan Kettering Cancer Center in New York told Live Science. “She said the tumor had just kind of dissolved.”

Chapman was lead author of the research report published in the New England Journal of Medicine about the trial, part of research needed for the FDA to approve combined use of the drugs.

The woman, and others in the trial, were treated with a process called immunotherapy — using drugs to boost a person’s own immune system to fight cancer. It’s a relatively new approach to treating deadly melanoma.

he patients were given two FDA-approved melonoma drugs already being used to treat the cancer, but not used in combination before — ipilimumab (sold under the brand name Yervoy) and nivolumab (brand name Opdivo).

Ipilimumab allows the body to override part of the immune system, turning loose waves of immune cells to kill cancer cells. Nivolumab strengthens certain immune cells, called “T cells,” preventing them from dying and allowing them to continue attacking cancer longer.

Chapman says the tests confirm a suspicion doctors and researchers have had for a long time that the immune system can fight cancer. This research may open new doors in unleashing that potential.

Fuente: www.goodnewsnetwork.org
SHARE
TWEET
To comment you must log in with your account or sign up!
Featured content